
26/10/2023
More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study
Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the end of March.
Oh, how poor I am!... No, I’m not poor, I’m richer in love than in words...
Вулиця Межигірська, 55/20, Київ, Украина
Kyiv
02000
Be the first to know and let us send you an email when Business Class posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Business Class: